Board Intelligence View
Enterprise performance for Q4 2025 shows revenue momentum (+3.1%) with EBITDA at 12.0% margin, in line with guidance. Two material risks require board attention this quarter.
APAC margin compression (–80bps) and unhedged commodity exposure ($420M) represent the primary EBITDA risk for Q1 2026. Supplier renegotiation is the highest-leverage action available.
Cash position remains strong at $620M. Net cash improved $42M quarter-over-quarter. Working capital program is yielding results: DSO improved by 3 days.
Authorize APAC supplier renegotiation mandate. CFO and Procurement to execute formal RFP by November 15.
Approve SKU rationalization program covering 23 value-destroying products. Revenue impact: $8M. Projected EBITDA recovery: $34M annually.
Instruct EMEA compliance team to accelerate regulatory remediation. Escalate to CEO if Q1 2026 deadline is at risk.
ILLUSTRATIVE DATA DISCLAIMER: All metrics, figures, risk assessments, and AI narratives shown in Board Mode are entirely illustrative and for demonstration purposes only. No actual company data, financial results, or risk assessments are represented. Not for investment, legal, or regulatory use.